Looks at the industry challenges and potential threats, and makes strategic recommendations for boosting market share
(PRWEB) February 19, 2013
The purpose of this TriMark Publications analysis is to describe the specific market segments of the over-the-counter (OTC) diagnostic products and home healthcare markets. It examines the diagnostic measurement devices and their reagents and supplies that are utilized in clinics and by patients directly in their homes to diagnose and monitor disease.
This study also includes a review of home healthcare kits and devices that measure health-related conditions. Focus is on market dynamics and current market drivers of the OTC and home self-testing diagnostics market.
This report also looks at the industry challenges and potential threats, and it makes strategic recommendations for boosting market share. The analysis covers healthcare-related devices that are designed for the home market in order to allow consumers to assess their health status through self-testing. In addition, this review examines some biowarfare detection systems.
The emphasis in this report is on those companies and products that are actively developing and marketing diagnostic reagents and supplies in market segments that are targeted for direct sale to the public.
Companies mentioned include: Abbott Diagnostics, Ani Biotech Oy, Bayer Corporation, Becton Dickinson (BD), LifeScan, A Menarini Diagnostics, Roche Diagnostics, Saliva Diagnostics, Trinity Biotech, Plc and many more
For further details please visit http://www.researchandmarkets.com/research/9l43dd/overthecounter
Research and Markets
Laura Wood, Senior Manager,
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716